Document:

Exhibit 10.1

 

March 16, 2006

 

 

Jeffrey
M. Leiden, MD, PhD

196
Beach Road

Glencoe,
Illinois  60022

Dear
Jeff:

 

 

This
letter will confirm our agreement with you relating to your departure from
Abbott Laboratories (“Abbott”). As used in this Agreement, the term “Abbott”
shall mean Abbott Laboratories and all of its subsidiaries and affiliates.

 

1.               Your last day of work for Abbott will be
March 24, 2006 (the “Separation Date”). You hereby tender your resignation as
an employee, officer and director of Abbott as of that date and as a director
of TAP.

 

2.               a.     You agree that through September 30, 2007,
you will not engage, directly or indirectly, in any activity (including but not
limited to participation on profit or non-profit Boards), business or
employment which is competitive with any businesses conducted by Abbott, or
that were or are under consideration by Abbott. You agree to notify Abbott, in
writing, of any intended activity, business or employment in which you propose
to engage and the name and address of any other intended future employer.
Abbott shall have the right to advise such person of your obligations
hereunder. If you so request, Abbott will notify you, in writing, of whether it
considers such activity, business or employment to be inconsistent with your
obligations hereunder.

 

b.              You will not disparage, and will cause your
attorneys, financial advisors and members of your immediate family not to
disparage Abbott, its products, personnel or persons representing them with
respect to business or personal matters. You will not engage in activities that
negatively affect Abbott’s reputation or its ongoing or planned areas of
operations, or its relationships with current or prospective customers and
suppliers.

 

b.              You agree to cooperate with Abbott with respect
to any charge, suit, investigation, claim or question arising regarding any
matter of which you had knowledge during your employment with Abbott. Such
cooperation will include, but not be limited to, appearance at depositions,
assistance in responding to discovery demands and in preparing for trial, and
appearance at trial. Abbott will reimburse you for all reasonable expenses,
including travel expenses, incurred by you in providing such assistance.

 

c.               You agree to make reasonable efforts for an
orderly business transition, and to maintain and protect the reputation of
Abbott, and its affiliates, businesses, products and personnel. You agree to
return all Abbott property in your possession, including without limitation,
computers,

 

 

blackberry, cellular
telephones, fax machines, reports, files, memoranda, keys, identification
cards, computer access codes, customer and client lists and other property or
materials which you have prepared or to which you have had access, and you
shall not retain any reproduction thereof.

 

d.              You agree to abide by the terms of your
Abbott Employment Agreement.

 

3.               In exchange for the foregoing, Abbott agrees
that it will cause all restrictions to lapse with respect to the 2002, 2004 and
2005 Restricted Stock Awards. You will forfeit in its entirety the 2006
Restricted Stock Award.

 

4.               In the event of your breach of the provisions
of paragraph 2, Abbott’s obligations hereunder shall cease and you agree to
promptly remit to Abbott all outstanding shares of restricted stock which
vested to you from the 2002, 2004 and 2005 Restricted Stock Awards and/or the
funds provided to you in connection with the sale thereof.

 

5.               Except as otherwise provided in paragraph 3,
you will be entitled to benefits under existing Abbott employee benefit plans,
in accordance with the terms of those plans, through your Separation Date.

 

6.               Except to the extent limited by subparagraph
7c and except for claims, demands, and causes of action (“Claims”) for the
nonperformance of this Agreement, Abbott and you hereby forever waive, release
and discharge each and the other, as well as the officers, directors,
employees, agents and shareholders of Abbott, from liability, as follows:

 

a.               With respect to any and all Claims
whatsoever, whether known or unknown, related to your employment by Abbott or
your resignation and termination of employment, (i) you hereby forever waive, release
and discharge Abbott and the officers, directors, employees, agents and
shareholders of Abbott from liability from all such Claims or in the future may
have, and (ii) Abbott hereby forever waives, releases and discharges you from
all such Claims.

 

b.              With respect to all other Claims whatsoever,
whether known or unknown, (i) you hereby forever waive, release and discharge
Abbott and the officers, directors, employees, agents and shareholders of
Abbott from liability from all such Claims you now have and (ii) Abbott hereby
forever waives, releases and discharges you from liability from all such Claims
Abbott now has.

 

Both
parties agree not to attempt to assert any such Claims at any time.

 

2

 

7.               The following provisions are included in
compliance with Section 7 of the Federal Age Discrimination in Employment Act
of 1967. You are hereby advised of the following:

 

a.               You acknowledge that this Agreement is
supported by consideration described in paragraph 3, to which you would not
otherwise be entitled.

 

b.              The release and agreement not to sue
contained in paragraph 6 apply to, among other things, any and all claims you
have against Abbott under the Federal Age Discrimination in Employment Act.

 

c.               This Agreement shall not be deemed to waive
any rights or claims relating to age discrimination arising after the date you
sign this Agreement.

 

d.              You acknowledge that you have been given the
opportunity to consult with attorneys of your choosing, financial advisors and
members of your immediate family.

 

e.               You have 21 days from the date of your
receipt of this Agreement to decide whether or not to sign it. You may take the
entire 21 days to decide whether to sign this Agreement and the offer contained
in this Agreement will remain open during that 21-day period.

 

f.                 You may revoke this Agreement, in writing, at
any time within seven days after you sign it, and this Agreement will not
become effective or enforceable until the eighth day following your signing of
it.

 

g.              You acknowledge that you have not relied on
any representation, written or oral, not set forth in this Agreement and that
you have entered into this Agreement voluntarily and with full knowledge of its
final and binding effect.

 

8.               You will be entitled to indemnification from
Abbott to the same extent as other current or former directors and officers of
Abbott. You also will be entitled to coverage under the directors and officers
liability insurance coverage maintained by Abbott (as in effect from time to
time) to the same extent as other current or former directors of Abbott;
provided, however, that nothing in this paragraph 8 will be construed to
require Abbott to continue to maintain any such directors or officers liability
insurance coverage.

 

9.               If any portion of this Agreement should be
ruled invalid, the balance of this Agreement shall continue in full force and
effect.

 

10.         This
Agreement shall be governed by, and construed in accordance with, the laws of
Illinois, regardless of the laws that might otherwise apply under applicable
conflicts of laws principle.

 

3

 

11.         This
Agreement constitutes the complete understanding between you and Abbott
relating to your departure and supersedes any and all prior agreements,
promises, representations, or inducements. No promises or agreements made
subsequent to the execution of this Agreement by these parties shall be binding
unless reduced to writing and signed by authorized representatives of these
parties. The Agreement regarding Change in Control dated June 20, 2003, between
you and Abbott is hereby terminated.

 

If
this letter accurately sets forth our understanding, please sign and return
this letter.

 

Sincerely,

 

	
  ABBOTT
  LABORATORIES

  
	
   

  
	
   

  
	
  By:

  	
  /s/ Stephen
  R. Fussell

  	
   

  	
   

  
	
   

  	
  Stephen
  R. Fussell

  	
   

  
	
   

  
	
   

  
	
  ACCEPTED:

  
	
   

  
	
  /s/ Jeffrey
  M. Leiden

  	
   

  	
   

  
	
  Jeffrey
  M. Leiden, MD, PhD

  
	
   

  
	
   

  
	
  Date:

  	
   3/16/06

  	
   

  	
   

  
						

 

4Exhibit 10.1

 

THIRD AMENDMENT
FORBEARANCE AGREEMENT

 

THIS THIRD AMENDMENT TO THE FORBEARANCE AGREEMENT (this
“Third Amendment”), dated as of March 14,
2006, is entered into among CURATIVE HEALTH
SERVICES, INC., a Minnesota corporation formerly known as Curative
Holding Co. (“Holdings”), EBIOCARE.COM, INC.,
a Delaware corporation (“eBioCare”), HEMOPHILIA ACCESS, INC., a Tennessee corporation (“Hemophilia Access”), APEX THERAPEUTIC CARE, INC., a
California corporation (“Apex”),
CHS SERVICES, INC., a
Delaware corporation (“CHS”),
CURATIVE HEALTH SERVICES OF NEW YORK, INC.,
a New York corporation (“CHSNY”),
OPTIMAL CARE PLUS, INC., a
Delaware corporation (“Optimal Care”),  INFINITY
INFUSION, LLC, a Delaware limited liability company (“Infinity”), INFINITY INFUSION II, LLC, a Delaware limited liability
company (“Infinity II”), INFINITY INFUSION CARE, LTD., a Texas
limited partnership (“Infinity Infusion”),
MEDCARE, INC., a Delaware
corporation (“Medcare”), CURATIVE PHARMACY SERVICES, INC., a
Delaware corporation (“CPS”),
CURATIVE HEALTH SERVICES CO., a
Minnesota corporation formerly known as Curative Health Services, Inc. (“CHSC”), CRITICAL CARE SYSTEMS, INC., a Delaware corporation (“CCS”) (Holdings, eBioCare, Hemophilia
Access, Apex, CHS, CHSNY, Optimal Care, Infinity, Infinity II, Infinity
Infusion, Medcare, CPS, CHSC and CCS are sometimes collectively referred to
herein as the “Borrowers” and individually as a “Borrower”), CURATIVE
HEALTH SERVICES III CO. (“Guarantor”)
Minnesota corporation, and GENERAL
ELECTRIC CAPITAL CORPORATION, a Delaware corporation (“GE Capital”), as Agent and Lender.

 

RECITALS:

 

A.
Pursuant to that certain Forbearance Agreement dated December 1,
2005 by and between Borrowers and GE Capital (the “Forbearance Agreement”), GE Capital
agreed to forbear on certain of its rights and obligations under an Amended and
Restated Credit Agreement, dated April 23, 2004, as amended by (i) that
certain First Amendment to Amended and Restated Credit Agreement and Collateral
Documents dated as of May 3, 2004, (ii) that certain Second Amendment
to Amended and Restated Credit Agreement dated as of June 30, 2004, (iii) that
certain Third Amendment to Amended and Restated Credit Agreement dated as of October 20,
2004 and (iv) that certain Fourth Amendment to Amended and Restated Credit
Agreement dated as of December 31, 2004 (as so amended, the “Credit Agreement”);

 

B.
By First Amendment to Forbearance Agreement (the “First
Amendment”) dated as of December 23, 2005 and Second Amendment to
Forbearance Agreement dated as of January 30, 2006 (the “Second Amendment”),
the parties amended certain terms of the Forbearance Agreement. As used herein,
the term Forbearance Agreement shall include the First Amendment and Second
Amendment.

 

C. The
parties hereto have agreed to further amend certain terms of the Forbearance Agreement
upon the terms and conditions and other requirements set forth herein.

 

 

NOW,
THEREFORE, in consideration of the foregoing, the terms and
conditions set forth in this Amendment, and other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, GE
Capital, the Borrowers and Guarantor agree as follows:

 

1.
Definitions:  Unless
otherwise defined herein, all capitalized terms herein shall have the meanings
assigned to such terms in the Forbearance Agreement.

 

2.
Confirmation of Representation and Warranties:  The
Borrowers and Guarantor hereby confirm that all of the representations and
warranties set forth in the Forbearance Agreement are true and correct with respect
to such Borrower.

 

3.
Enforceability: This Third Amendment constitutes the
legal, valid and binding obligation of the Borrowers and Guarantor, and is
enforceable against Borrowers and Guarantor according to its terms.

 

4.
Effective Date: This Third Amendment shall be effective
upon execution and delivery to GE Capital of this Third Amendment by Borrowers
and Guarantor.

 

5. Costs: Borrowers shall be responsible
for the payment on demand of all reasonable out-of-pocket costs and expenses of
GE Capital heretofore or hereafter incurred, which are related to or in
connection with this Third Amendment and any documents, agreements or
instruments executed in connection herewith or therewith including, without
limitation, the reasonable fees and expenses of the consultants, attorneys or
other professionals retained by GE Capital (the “Documentation Fees”). Nothing in this Third Amendment
shall be intended or construed to hold the Agent or the Lenders liable or
responsible for any expense, liability or obligation of any kind or nature
whatsoever incurred by the Borrowers or any Guarantor (including, without
limitation, attorneys’ fees and expenses, other professionals’ fees and
expenses, any crisis manager’s fees and expenses, wages, salaries, payroll
taxes, withholdings, benefits or other amounts payable by or on behalf of the
Borrowers or any Guarantor). Additionally, GE Capital may reserve from the
amounts otherwise available to the Borrowers as a Revolving Credit Advance such
amounts necessary to pay the Documentation Fees.

 

6. Amendments to the Forbearance
Agreement:
Effective as of the date of this Third Amendment, the following provision of
the Forbearance Agreement is amended:

 

(a)                                  Sections 7(c)(v) and 7(c)(vi) are
deleted and replaced with the following:

 

(v)  File Chapter 11 on or before March 28, 2006.

(vi) Confirm a Chapter 11 case on or before June 30, 2006.

 

7. Reference to the Effect on
the Forbearance Agreement:

 

(a) Upon the effectiveness of this Third
Amendment, each reference in the Forbearance Agreement to “this Agreement,” “hereunder,”
“hereof,” “herein” or words of similar import shall mean and be a reference to
the Forbearance Agreement as amended by this Third Amendment.

 

 

(b) Except as specifically amended
above, the Forbearance Agreement, and all other documents related to the Credit
Agreement, shall remain in full force and effect, and are hereby ratified and
confirmed.

 

(c)  The execution, delivery and effectiveness
of this Third Amendment shall not, except as expressly provided in this Third
Amendment, operate as a waiver of any right, power or remedy of GE Capital, nor
constitute a waiver of any provision of the Forbearance Agreement, or any other
documents, instruments and agreements executed or delivered in connection with
the Credit Agreement and/or the Forbearance Agreement. GE Capital reserves all
of its rights under the Credit Agreement and the Forbearance Agreement.

 

8. Governing Law:    This Third
Amendment shall be governed by and construed in accordance with the laws of the
State of New York.

 

9. Headings: Section headings in this Third
Amendment are included for convenience purposes only and shall not constitute a
part of this Third Amendment for any other purpose.

 

10. Counterparts: This Third Amendment may be
executed in counterparts, and both counterparts taken together shall be deemed
to constitute on and the same instrument. This Third Amendment may be
executed by facsimile.

 

IN WITNESS WHEREOF, the parties hereto have
caused this Third Amendment to be acknowledged, executed and delivered by their
duly authorized officers as of the date first above written.

 

 

	
   

  	
  LENDER AND AGENT:

  
	
   

  	
   

  
	
   

  	
  GENERAL ELECTRIC CAPITAL CORPORATION

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Richard T. Arrowsmith

  	
   

  
	
   

  	
  Name:

  	
  Richard T. Arrowsmith

  	
   

  
	
   

  	
  Title:

  	
  Its Duly Authorized Signatory

  

 

 

[BORROWERS’
SIGNATURES CONTINUE ON NEXT PAGE]

 

	
   

  	
  BORROWERS:

  
	
   

  	
   

  
	
   

  	
  CURATIVE
  HEALTH SERVICES, INC.,

  
	
   

  	
  a
  Minnesota corporation formerly known as

  Curative Holding Co.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  

 

 

	
   

  	
  EBIOCARE.COM, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  HEMOPHILIA
  ACCESS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  APEX
  THERAPEUTIC CARE, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  

 

 

	
   

  	
  CHS
  SERVICES, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  CURATIVE
  HEALTH SERVICES OF NEW

  YORK, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  OPTIMAL
  CARE PLUS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  INFINITY
  INFUSION, LLC

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., its Sole

  Member

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  

 

 

	
   

  	
  INFINITY
  INFUSION II, LLC

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., its Sole

  Member

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  INFINITY
  INFUSION CARE, LTD.

  
	
   

  	
   

  
	
   

  	
  By:
  Infinity Infusion II, LLC, its Sole General

  Partner

  
	
   

  	
   

  
	
   

  	
  By:
  Curative Health Services Co., the Sole

  Member of Infinity Infusion II, LLC

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  MEDCARE, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
  CURATIVE
  PHARMACY SERVICES, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  Treasurer

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  

 

 

	
   

  	
  CURATIVE
  HEALTH SERVICES CO.,

  
	
   

  	
  a
  Minnesota corporation formerly known as

  Curative Health Services, Inc.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  CRITICAL
  CARE SYSTEMS, INC.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

  	
   

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  GUARANTOR:

  
	
   

  	
   

  
	
   

  	
  CURATIVE HEALTH SERVICES III CO.

  
	
   

  	
   

  
	
   

  	
   

  
	
   

  	
  By:

  	
   

  	
  /s/ Thomas Axmacher

  	
   

  
	
   

  	
  Name:

  	
  Thomas Axmacher

  	
   

  
	
   

  	
  Title:

  	
  C.F.O.

  	
   

  
	
   

  	
  Date:

  	
  March 15, 2006

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00100-of-00352.parquet"}]]